As the co-founder and CEO of DrugStoc, he is at the forefront of a revolution that aims to solve some of the continent’s most pressing healthcare challenges, including access to quality medicines, combating counterfeit drugs, and improving the overall efficiency of the pharmaceutical distribution network.
Opara’s journey into the healthcare sector began with a strong academic background, having pursued a degree in medicine, which gave him firsthand experience with the healthcare system’s complexities and shortcomings.
This foundation in medicine equipped him with an in-depth understanding of the challenges faced by healthcare providers, especially in sourcing and managing pharmaceutical supplies.
He co-founded DrugStoc with the vision of creating a robust and reliable supply chain for pharmaceuticals in Africa.
The idea stemmed from his experiences as a medical professional, where he encountered frequent disruptions in the supply of essential medications.
He realized that these supply chain inefficiencies were contributing to a larger problem: the prevalence of counterfeit drugs in the market.
DrugStoc was established to tackle these issues by providing a technology-driven solution. The platform connects healthcare providers with verified suppliers, ensuring a seamless and transparent process for sourcing genuine medications.
By leveraging technology, DrugStoc enhances the efficiency of the pharmaceutical supply chain, reduces costs, and minimizes the risk of counterfeit drugs entering the market.
Under Opara’s leadership, DrugStoc has grown to become a critical player in the healthcare sector, improving access to quality medicines for clinics, hospitals, and pharmacies across Nigeria and beyond.
Through DrugStoc, Opara aims to create a healthcare ecosystem where every patient has access to safe, effective, and affordable medications.
This vision aligns with the broader goal of achieving universal healthcare coverage in Africa, where many people still struggle to access basic healthcare services.